About this trial
Many patients stop medication-based treatments for Opioid Use Disorder (OUD) prematurely, placing them at increased risk for overdose and death. Providing targeted interventions for OUD, particularly through an accessible, digital health platform, is a potential way to enhance recovery and keep patients engaged in care. The current study seeks to test whether a digital mental health platform, delivered by peer recovery support specialists to individuals prescribed buprenorphine or methadone medication, will improve treatment outcomes for this high risk population.
Eligibility criteria
Qualifiers
Age 22+
Current Opioid Use Disorder diagnosis
Prescribed buprenorphine or methadone
Initiated or reinitiated buprenorphine or methadone treatment recently
Disqualifiers
Not fluent in English
Limited mental capacity or inability to provided informed consent
Trial design
Treatments tested in this trial
- Vira Platform
- Treatment-As-Usual
Treatment groups
Sponsors and collaborators
Rhode Island Hospital
Lead sponsor
Ksana Health
Collaborator